Ultralife (NASDAQ:ULBI) Stock Price Passes Above 200-Day Moving Average – Should You Sell?

Ultralife Corporation (NASDAQ:ULBI) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $6.28 and traded as high as $7.25. Ultralife shares last traded at $6.91, with a volume of 32,557 shares.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded Ultralife from a “sell (d)” rating to a “sell (d+)” rating in a report on Thursday, May 28th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Ultralife presently has a consensus rating of “Sell”.

Ultralife Stock Performance

The stock has a market capitalization of $111.46 million, a PE ratio of -13.38 and a beta of 0.75. The firm’s fifty day moving average is $6.84 and its 200-day moving average is $6.29. The company has a current ratio of 2.56, a quick ratio of 1.23 and a debt-to-equity ratio of 0.34.

Ultralife (NASDAQ:ULBI) last issued its quarterly earnings data on Friday, May 8th. The technology company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.18). The company had revenue of $47.45 million during the quarter, compared to analysts’ expectations of $52.40 million. Ultralife had a negative net margin of 4.37% and a positive return on equity of 1.15%.

Insider Transactions at Ultralife

In related news, Director Bradford T. Whitmore acquired 67,302 shares of Ultralife stock in a transaction that occurred on Tuesday, May 26th. The shares were purchased at an average cost of $6.81 per share, for a total transaction of $458,326.62. Following the acquisition, the director owned 2,050,637 shares in the company, valued at approximately $13,964,837.97. This represents a 3.39% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In the last 90 days, insiders have bought 110,878 shares of company stock valued at $726,948. 40.00% of the stock is currently owned by insiders.

Institutional Trading of Ultralife

Institutional investors and hedge funds have recently bought and sold shares of the stock. Janney Montgomery Scott LLC grew its position in Ultralife by 2.0% in the 1st quarter. Janney Montgomery Scott LLC now owns 518,000 shares of the technology company’s stock valued at $3,377,000 after acquiring an additional 10,200 shares in the last quarter. Empowered Funds LLC acquired a new position in Ultralife in the 4th quarter valued at about $44,000. XTX Topco Ltd grew its position in Ultralife by 19.9% in the 4th quarter. XTX Topco Ltd now owns 15,456 shares of the technology company’s stock valued at $88,000 after acquiring an additional 2,569 shares in the last quarter. Rothschild Wealth LLC acquired a new position in Ultralife in the 4th quarter valued at about $400,000. Finally, Heron Bay Capital Management acquired a new position in Ultralife in the 4th quarter valued at about $127,000. 30.68% of the stock is currently owned by hedge funds and other institutional investors.

Ultralife Company Profile

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.